Patriot Financial Group Insurance Agency, LLC Capricor Therapeutics, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	SELL	$3.43 - $5.23 $514 - $784	-150 Closed	0 $0
Q3 2020 Oct 21, 2020	SELL	$4.08 - $9.81 $3,468 - $8,338	-850 Reduced 85.0%	150 $1,000
Q2 2020 Jul 10, 2020	BUY	$1.0 - $8.5 $1,000 - $8,500	1,000 New	1,000 $5,000

Others Institutions Holding CAPR

# of Institutions

Shares Held

8.1M

Call Options Held

1.78M

Put Options Held

1.4M

Black Rock Inc. New York, NY

1.63M
Shares

$29.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.58M
Shares

$28.9 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

638K
Shares

$11.7 Million
0.0% of portfolio
State Street Corp Boston, MA

512K
Shares

$9.4 Million
0.0% of portfolio
Superstring Capital Management LP New York, NY

337K
Shares

$6.19 Million
4.49% of portfolio

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $447M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account